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Purpose: We investigated the incidence and risk factors of hypothyroidism after thyroid lobectomy, and evaluated the possi-
bility to predict hypothyroidism preoperatively with serologic markers, such as thyrotropin (TSH), thyroglobulin (TG), an-
ti-thyroglobulin (ATA), and anti-microsomal antibody (AMA). Methods: We enrolled 123 consecutive patients who under-
went thyroid lobectomy due to benign conditions between May 2004 and April 2008. Only preoperative euthyroid patients 
were included. Patients were divided into two groups by postoperative thyroid function outcomes, into hypothyroid (n = 97) 
and euthyroid groups (n = 26), and analyzed specially for the preoperative levels of TSH, TG, ATA, and AMA. Results: 
Twenty-six (21.1%) patients developed hypothyroidism following thyroid lobectomy within 35.7 months of follow-up. The 
proportion of post-lobectomy hypothyroidism was high in patients with high-normal preoperative TSH level, and the cut-off 
value was 2.0 mIU/L, with 67% sensitivity and 75% specificity. The quantitative titer of preoperative TG, ATA, and AMA was 
not significant, but the outcome of categorical analysis of two or more positivities on these three markers was significantly 
higher in hypothyroid patients than in euthyroid patients (28.6% vs. 3.9%, P = 0.024). The combined positivity of preoperative 
TSH and two or more positivities of TG, ATA, and AMA possess 100% positive predictive value and 81% negative predictive 
value. Conclusion: The incidence of hypothyroidism following thyroid lobectomy was 21.1%. High-normal preoperative 
TSH and two or more positivities for TG, ATA, and AMA are good pre-operative predictive markers. Such high-risk patients 
need close TSH monitoring before the onset of clinical hypothyroidism.
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INTRODUCTION
With reported rates between 6.5 and 45% in the liter-
ature [1-4], hypothyroidism following lobectomy or 
hemi-thyroidectomy (if additional isthmectomy was per-
formed) remains an inevitable sequelae. In the past, it was 
common practice to prescribe suppressive dosage of levo-
thyroxine after thyroid lobectomy. However, its effect on 
preventing the formation of nodules in the remaining thy-
roid and its adverse effects, such as atrial fibrillation and Hypothyroidism after thyroid lobectomy
thesurgery.or.kr 381
bone calcium loss, remain unclear and render clinicians re-
luctant to encourage patients to take daily thyroid re-
placement.
Many studies have attempted to identify the risk factors 
for post-lobectomy hypothyroidism, and to reduce post-
operative thyroid hormone replacement. Many risk fac-
tors have been suggested, including age [5], high serum 
thyrotropin (TSH) levels [4-6], lower free T4 levels [7], and 
the presence of thyroid antibodies [4] preoperatively. In 
contrast, we can see the results of thyroiditis [2,4], residual 
thyroid volume [8], thyroiditis [4], multinodular goiter [6], 
and small thyroid remnant after thyroid lobectomy after 
surgery [2,6]. There exist only one report on a preoperative 
predictive study of hypothyroidism. Tomoda et al. [5] sug-
gested a predictive scoring system based on preoperative 
TSH levels and age. No other study predicted post lobec-
tomy hypothyroidism preoperatively.
Thyroiditis is the end result of inflammatory process by 
thyroid antigens and its antibodies [9], and subclinical 
thyroiditis is predictable through anti-thyroglobulin 
(ATA) and anti-microsomal antibody (AMA) preopera-
tively [10]. The objectives of this study were to determine 
the incidence, risk factors, and ability to predict hypo-
thyroidism preoperatively by using TSH, thyroglobulin 
(TG), ATA, and AMA.
METHODS
This was a retrospective study that included consec-
utive patients who underwent thyroid lobectomy due to 
benign conditions between May 2004 and April 2008. 
Clinical and pathologic data were available in 123 pa-
tients, but 26 patients did not have serologic data, partic-
ularly TG, ATA and AMA.
Surgical procedure was performed by two experienced 
surgeons (Jegal YJ and Yoon JH) at our institution, with 
classic low cervical incision, minimal invasive lobectomy, 
and via the endoscopic approach. Hemi-thyroidectomy 
usually involves lobectomy and isthmectomy at the same 
time, but it remains difficult to define isthmectomy 
precisely. Thus, hemi-thyroidectomy was defined if the 
thyroid beyond the centerline of trachea was resected and 
confirmed by follow-up ultrasonography.
Only preoperative euthyroid patients were included 
(normal range, 0.5 to 6.0 mIU/L) in this study, and patients 
with TSH levels greater than 6.0 mIU/L were diagnosed 
with hypothyroidism. All patients with preoperative hy-
pothyroidism, radiation history, thyroid surgery, pre- 
medication to control thyroid function with levothyroxine 
or anti-thyroid drugs were excluded. Patients psychologi-
cally dependent on levothyroxine with TSH levels ＜6.0 
mIU/L were excluded. Patients who received less than 6 
months of follow-up or those who did not undergo pre-
operative TG, ATA, and AMA evaluation were also 
excluded. If patients did not return for follow-up one year 
after the last follow-up, summons was obtained by tele-
phone and included in this study.
Patients were followed up at 3 to 6 months intervals 
during the first two postoperative years, and annually 
thereafter. At each visit, we took careful history of hypo-
thyroidism symptoms and checked serum thyroid hor-
mone levels. Neck ultrasonography was performed for 
suspected recurrence of benign or malignant nodular 
lesions. No patient required completion thyroidectomy of 
the contralateral lobe during the follow-up period. Most 
patients who developed postoperative hypothyroidism 
were commenced with levothyroxine, but some were de-
layed a few months later.
The preoperative and postoperative follow-up profiles 
of all patients were analyzed. 1) Preoperative assessment 
included patient demographics, laboratory and hormonal 
assays including preoperative TSH, TG, ATA, and AMA. 
2) Surgical factors included approach, laterality of thyroid 
lobectomy and the extent of isthmus ablation. 3) Postoper-
ative assessment included pathology, portion and size of 
benign tumors and the presence of thyroiditis. Histologic 
thyroiditis was graded on a scale of 0 to 4 according to 
Williams and Doniach [11], and scoring was performed by 
pathologists who were blind to the laboratory data and 
operative findings.
Patients were divided into two groups: hypothyroid (n 
= 97) and euthyroid (n = 26) state after thyroid lobectomy 
for benign conditions. The parameters discussed above 
were compared. We used the t-test to compare continuous 
variables between each group and the chi-square test for Jin Seong Cho, et al.
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Table 1.  Patient demographics and clinical findings
Post lobectomy
euthyroid
Post lobectomy
hypothyroid
P-value
Patients per groups    97 (78.9)   26 (21.1)
  Age (yr)    40.2 (13-66)  40.1 (18-68)    0.964
  Sex    0.283
    Male     30 (30.9)      6 (23.1)
    Female      67 (69.1)    20 (79.6)
Follow-up (mo)  33.0 (6-80) 38.3 (6-80)    0.340
Operation approach
   Classic low cervical
   Minimal invasive
   Endoscopic
    65 (67.0)
    17 (17.5)
    15 (15.5)
   16 (61.5)
      4 (15.4)
      6 (23.1)
 0.206
      0.353
a)
   Right lobectomy     52 (53.6)    10 (38.5)    0.238
   Hemithyroidectomy
b)     41 (42.3)      8 (30.8)     0.247
Tumor pathology
   Nodular hyperplasia
   Thyroid follicular adenoma
   Hurthle cell adenoma
    41 (42.3)
    51 (52.6)
    5 (5.2)
    10 (38.5)
    11 (42.3)
      5 (19.2)
    0.392
Tumor portion
   Upper 
   Middle 
   Lower
    14 (14.4)
    67 (69.1)
    16 (16.5)
      3 (11.5)
    16 (61.5)
      7 (26.9)
    0.314
Tumor size (cm)        2.3 (0.5-6.0)       2.5 (0.5-7.0)    0.518
Thyroiditis 8/68 (11.8) 3/18 (16.7)     0.635
Postoperative TSH (mIU/L)        2.5 (0.5-6.0)      9.5 (6.1-29) ＜0.001
Values are presented as number (%) or median (range).
TSH, thyroid stimulating hormone.
a)Endoscopic versus others. 
b)Lobectomy and isthmectomy. 
categorical variables. Binary logistic regression test was 
used for multivariate analysis of statistically significant 
variables from the univariate analysis. We consider stat-
istical significance when the P-value was less than 0.05 (P 
＜  0.05). Results were analyzed by using PASW ver. 18.0 
(SPSS Inc., Chicago, IL, USA).
RESULTS
Patient demographics and pathologic results
Of the 123 patients, 26 (21.1%) developed hypo-
thyroidism following thyroid lobectomy and 97 remained 
euthyroid. The mean length of follow-up was 35.7 months 
(range, 6 to 80 months). Age, sex, follow-up period and op-
eration type were not significant factors for  post-lobec-
tomy hypothyroidism development. A total of 108 pa-
tients underwent classic open surgery through low cer-
vical incision, 21 patients underwent minimal incision 
with less than 3.0 cm in length and 21 via the endoscopic 
approach. The operation approach (P = 0.206), laterality (P 
= 0.238) and isthmus ablation (P = 0.237) were not sig-
nificant factors. The pathologic characteristics of the re-
sected thyroid tissue did not show significant difference in 
pathology, portion, tumor size, and the presence of histo-
logic thyroiditis (P = 0.635).
Only postoperative TSH was significantly different (P 
＜  0.001) in the euthyroid group (median TSH, 2.5 mIU/L; 
range, 0.5 to 6.0 mIU/L) compared with the hypothyroid 
group (median TSH, 9.5 mIU/L; range, 6.1 to 29 mIU/L) 
(Table 1).
Preoperative TSH, TG, ATA, and AMA
We assumed high normal preoperative TSH levels and 
subclinical thyroiditis to be factors for post-lobectomy hy-
pothyroidism, as is in other studies [2,4]. The proportion Hypothyroidism after thyroid lobectomy
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Table 2. Preoperative TSH levels and serologic markers
Post lobectomy
euthyroid
Post lobectomy
hypothyroid
P-value
  Available patients                       76                     21
  TSH (mIU/L)
    ＜1.0-1.9
       1.47 (0.02-4.22)
   57 (74.9)
       2.90 (1.34-5.00)
     7 (33.3)
＜0.001
     2.0-5.9   19 (24.9)   16 (66.6)
  Histologic thyroiditis 8/68 (11.8) 3/18 (16.7)    0.635
  Quantitative titers of TG, ATA, and AMA
     TG
a)
     ATA
b)
     AMA
c)
    49.5 (3.0-830)
     15.0 (1.0-624)
       8.0 (5.0-253)
    49.0 (5-4550)
      19.5 (3.0-492)
      20.2 (9.9-970)
   0.726
    0.978
    0.225
  Categorical analysis on TG, ATA and AMA positivity
     All negative
     1 positive
     2 or more positive
 34 (44.7)
  39 (51.3)
  3 (3.9)
    6 (28.6)
     9 (42.8)
     6 (28.6)
   0.429
    0.183
    0.024
Values are presented as number, median (range) or number (%).
TSH, thyroid stimulating hormone; TG, thyroglobulin; ATA, anti-thyroglobulin antibody; AMA, anti-microsomal antibody.
a)Positive ＞  60 ng/mL. 
b)Positive ＞  120 IU/mL.
 c)Positive ＞  35 U/mL.
Table 3. Multivariate logistic regression for predictive factors in 
relation to postoperative hypothyroidisms in benign thyroid 
disease
Factors β  (SE) P-value
Exp 
(β)
95% CI Exp (β)
Lower Upper
Preoperative TSH 
 (2.0-5.9 mIU/L)
1.558 0.008 4.749 1.509 14.943
2 or more positivity
 on TG, ATA and AMA
2.250 0.006 9.492 1.898 47.462
SE, standard error; CI, confidence interval; TSH, thyroid 
stimulating hormone; TG, thyroglobulin; ATA, anti-thyroglobulin 
antibody; AMA, anti-microsomal antibody.
of post-lobectomy hypothyroidism was higher normal 
side (TSH 2.0 to 5.9 mIU/mL) distributed and statistically 
significant (P ＜ 0.001) in preoperative TSH levels. The 
cut-off value of preoperative TSH was 2.0 mIU/L, and the 
area under curve was 0.841, 95% confidence interval (CI): 
(0.76 to 0.92) (Table 2). As thyroid lobectomy reduces func-
tioning thyroid tissue, patients whose thyroid glands were 
at the limit of their capacity preoperatively, as indicated by 
elevated TSH, are likely to deteriorate. Therefore, a “nor-
mal” preoperative TSH encompasses a wide range of thy-
roid status [4].
Thyroiditis is the end result of an inflammatory process 
caused by thyroid antigens and its antibodies [9] and sub-
clinical thyroiditis is predictable through ATA and AMA 
[10]. Although the presence of histologic thyroiditis in the 
resected specimens was not significant in post-lobectomy 
hypothyroidism patients (P = 0.063), we reviewed pre-
operative TG, ATA, and AMA in all patients. Their quanti-
tative titers were not significant, and positivity was de-
fined as follows: TG ＞  60 ng/mL, ATA ＞  120 IU/mL, and 
AMA above 35 U/mL. Categorical analysis of two or more 
positivity of these three markers - serologic thyroiditis - 
was significantly higher in hypothyroid than euthyroid 
patients (28.6% vs. 3.9%, P = 0.024) (Table 2). 
Predictors of post lobectomy hypothyroidism
The relationship between post-lobectomy hypothy-
roidism and several clinicopathologic factors among the 
123 patients were analyzed through multivariate analysis. 
The incidence of post-lobectomy hypothyroidism is sig-
nificantly higher in those with higher preoperative TSH be-
tween 2.0 and 5.9 mIU/L (P = 0.008, odds ratio [OR] = 4.749) 
and patients with two or more positivity on preoperative 
TG, ATA, and AMA (P = 0.006, OR = 9.492) (Table 3). These 
were independent predictive factors of hypothyroidism 
after thyroid lobectomy. In addition, the combined pos-
itivity of preoperative TSH between 2.0 and 5.9 mIU/L and 
two or more positivity of TG, ATA, and AMA exhibited 
100% positive predictive value and 80.8% negative pre-Jin Seong Cho, et al.
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Table 4. Predictors of hypothyroidism
Sensitivity Specificity
Predictive value
Positive Negative
Preoperative high normal TSH (2.0-5.9 mIU/L) 66.6 75.0 42.4 89.1
Two or more positivity on TG, ATA, AMA 28.5 96.1 66.7 82.9
All of above 14.2 100 100 80.8
TSH, thyroid stimulating hormone; TG, thyroglobulin; ATA, anti-thyroglobulin antibody; AMA, anti-microsomal antibody.
Fig. 1. T i m e  c o u r s e  o f  h y p o t h y -
roidism after thyroid lobectomy. 
Routine thyroid function test moni-
toring was performed at 3, 6, 12, 18th 
month after surgery. About 10%, 5% 
and 14% of patients experienced 
overt clinical hypothyroidism at 3, 9 
and 18 months respectively.
dictive value (Table 4). It should be emphasized that these 
factors can be clearly identified preoperatively.
Time course of hypothyroidism after thyroid lo-
bectomy
In the past, we recommended routine TSH monitoring 
at 3, 6, and one year after surgery, then once or twice a year 
thereafter. Most new onset hypothyroidism is observed in 
routine screening at 3, 6 months and 1 year after surgery, 
and 72% of patients were diagnosed by one year and 96% 
by two years. However, 29% of patients (10% at 3 months, 
5% at 9 months, and 14% at 18 months) experienced overt 
clinical hypothyroidism, and all these patients had high 
normal TSH and two or more positivity on TG, ATA, and 
AMA (Fig. 1).
DISCUSSION
Many studies have attempted to evaluate the incidence 
and risk factors for hypothyroidism following thyroid lo-
bectomy and hemi-thyroidectomy. Many studies have re-
ported an incidence between 10.9 and 36.3% [1-4,12-15]. 
Various risk factors, such as age, high TSH levels, lower 
free T4 levels, presence of thyroid antibodies, and histo-
logic thyroiditis have been reported. If pre-surgical pre-
dictive factors can be identified, patients’ thyroid status 
will be optimally managed after surgery. However, there 
exists only one report on a preoperative predictive study. 
Tomoda et al. [5] suggested a predictive scoring system by 
using preoperative TSH levels and age. Other studies did 
not predicted hypothyroidism after thyroid lobectomy be-
fore surgery.
A prevalence of 21.1% of post-lobectomy hypo-
thyroidism is comparable to that of previous studies 
[4,5,8], and high normal preoperative TSH levels between 
2.0 and 5.9 mIU/L and two or more positivity on TG, ATA 
and AMA clearly increased the risk of hypothyroidism af-
ter thyroid lobectomy. Many studies reported that hypo-
thyroid patients after lobectomy have higher preoperative Hypothyroidism after thyroid lobectomy
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TSH when compared with euthyroid patients [6,12]. A 
preoperative TSH levels were lower side distribution in 
euthyroid group, and evenly and slightly higher side dis-
tributed in hypothyroid group. The cut-off value was 2.0 
mIU/L, with 66.6% sensitivity and 75.0% specificity, with 
area under curve was 0.841, 95% CI: 0.758 to 0.923 for the 
prediction of post-lobectomy hypothyroidism (Table 2).
In contrast to previous studies, age, sex, isthmusectomy, 
laterality of lobectomy and histologic thyroiditis were not 
significant factors for post-lobectomy hypothyroidism. In 
histologic thyroiditis, circulating auto-antibodies were in-
itially thought to be the cause of the inflammatory process, 
but thyroiditis do not necessarily correlate with the level 
of circulating antibodies [9]. It appears as an end result of 
serologic thyroiditis - increased inflammatory process by 
circulating antibodies - and predictable by TG, ATA, and 
AMA [10]. It was significant at 67% sensitivity and 83% 
specificity to predict post-lobectomy hypothyroidism th-
rough TG, ATA, and AMA in our study. In contrast to his-
tologic thyroiditis [2,4,15], we are able to obtain the results 
of serologic thyroiditis before surgery.
The mean age of the postoperative hypothyroid group 
was 40.1 years, compared with 40.2 years of the post-
operative euthyroid group. Although hypothyroidism is 
more prevalent among elderly patients [16], our study did 
not find old age to be a risk factor for the development of 
hypothyroidism.
In benign thyroid conditions surgeons try to leave as 
much remnant thyroid tissues as possible, including the 
isthmus [17]. More thyroid tissue is ablated and harvested 
in endoscopic thyroid lobectomy. For comport handling of 
endoscopic procedure, isthmus usually transected be-
yond the centerline of trachea, and grasped and tracted 
with endoscopic forceps. All of isthmusectomy of hypo-
thyroid group was endoscopic approach. Endoscopic thy-
roid lobectomy was slightly more common in hypo-
thyroid (23.8% vs. 10.5%) patients albeit without sig-
nificance (P = 0.203). Likewise for isthmusectomy (P = 
0.191).
We recommended patients to evaluate their thyroid 
function at 3, 6 months, and 1 year after surgery, then once 
or twice a year thereafter for low risk patients. Additional 
thyroid function monitoring at 2 and 9 months was op-
tional for high-risk patients. All patients were educated 
with symptoms of hypothyroidism, and most patients en-
dured hypothyroidism with TSH higher than 10 IU/mL 
without experiencing serious symptoms. However, 29% of 
patients experienced overt clinical hypothyroidism. As 
such, we recently added TSH at 1, 9, and 18 months of fol-
low-up as routine monitoring for high risk patients, such 
as preoperative TSH between 2.0 and 5.9 mIU/L, and two 
or more positivity of TG, ATA, and AMA.
This study is limited by its retrospective nature and 
asymptomatic subclinical hypothyroid patients - normal 
T3 and free T4 levels but 6 mIU/L or higher TSH levels - 
was defined as hypothyroid and required thyroid replace-
ment therapy. To support this, there was significant rise in 
postoperative TSH that peaked at 1 to 2 months. TSH lev-
els in patients not treated with levothyroxine was the low-
est at 3 months and increased subsequently [5]. Also, some 
patients with asymptomatic subclinical hypothyroidism 
were delayed for thyroid replacement. Tracking thyroid 
function tests were performed after 1 month but all experi-
enced clinical hypothyroidism.
In conclusion, patients who undergo thyroid lobectomy 
should be counseled for thyroid replacement therapy 
[4,5,8]. This is significantly higher than those who have 
high normal preoperative TSH levels and who have two or 
more positivity on TG, ATA, and AMA. And these were in-
dependent predictive factors of hypothyroidism after thy-
roid lobectomy. The combined positivity of them had 
100% positive predictive value and 80.8% negative pre-
dictive value. We recommend patient to evaluate their thy-
roid function at 3 and 6 months, and 1 year after surgery 
for low risk patients. Additional TSH monitoring at 1, 9, 
and 18 months should be performed for high-risk patients.
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